The Wegovy pill is still dominating the GLP-1 pill market
MarketWatchPaywall
Read Full Article at MarketWatch →Ad Slot — In-Article (728x90)
It has remained a top choice among Americans trying to lose weight even after the launch of Foundayo, Eli Lilly’s GLP-1 pill.
This is a summary. For the full story, read the original article at MarketWatch.
Original source: MarketWatch